We assessed the prevalence of metabolic dysfunction‐associated steatotic liver disease (MASLD) and significant liver fibrosis in adults with type 1 diabetes mellitus (T1DM) and the association of MASLD with insulin sensitivity and continuous glucose monitoring metrics. This evidence concerns the gene INS and Hepatic fibrosis.